Sector: Healthcare | Industry: Pharmaceuticals |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 8950 SW 74TH CT, SUITE 101 MIAMI FL 33156 |
Tel: | N/A |
Website: | https://www.earthsciencetech.com |
IR: | See website |
Key People | ||
Giorgio R. Saumat Chairman of the Board, Chief Executive Officer | Ernesto Flores Chief Financial Officer | Mario Tabraue Chief Operating Officer |
Christopher Rose Chief Technology Officer | Steven Warm Chief Legal Counsel |
Business Overview |
Earth Science Tech, Inc. is a holding company in the compounding pharmaceuticals and telemedicine sectors, through its wholly owned subsidiaries, RxCompoundStore.com, LLC. (RxCompound), Peaks Curative, LLC. (Peaks), and Earth Science Foundation, Inc. (ESF). RxCompound is a complete compounding pharmacy. RxCompound is licensed to fulfill prescriptions in the states of Florida, New York, New Jersey, Delaware, Pennsylvania, Rhode Island, Nevada, Colorado, and Arizona. Peaks is a telemedicine referral site focused on men's health. Peaks orders are fulfilled by RxCompound. Patients who order Peaks via monthly subscription receive their refills automatically. Peaks is focused on men's health, and, more specifically, ED. ESF accepts grants and donations to help those in need of assistance in paying for prescriptions. |
Financial Overview |
For the nine months ended 31 December 2023, Earth Science Tech Inc revenues increased from $3K to $5.9M. Net income totaled $580K vs. loss of $130K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Litigation Expense decrease of 100% to $2K (expense), Cost of legal proceedings decrease from $18K (expense) to $0K, Interest SBA Loan decrease from $2K (expense) to $0K. |
Employees: | 8 as of Mar 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $18.62M as of Dec 31, 2023 |
Annual revenue (TTM): | $5.98M as of Dec 31, 2023 |
EBITDA (TTM): | $0.17M as of Dec 31, 2023 |
Net annual income (TTM): | $0.33M as of Dec 31, 2023 |
Free cash flow (TTM): | $0.01M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $0.04M as of Dec 31, 2023 |
Shares outstanding: | 314,850,730 as of Dec 31, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |